Search results
Factor XII Deficient Plasma
Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
Factor XI Deficient Plasma
Measurement of Factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor XI Deficient Plasma
Measurement of factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
Factor IX Deficient Plasma
Measurement of factor IX (FIX) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FIX deficient plasma is required.
Plasminogen, Human
Recommended for any research study on fibrinolysis.
Antithrombin, Human
Recommended for any study on heparin and glyco-amino-glycans. Useful for designing heparin assays (clotting or chromogenic) where a source of AT is required.
Antithrombin, Human
Recommended for any study on heparin and glyco-amino-glycans. Useful for designing heparin assays (clotting or chromogenic) where a source of AT is required.
Antithrombin, Human
Recommended for any study on heparin and glyco-amino-glycans. Useful for designing heparin assays (clotting or chromogenic) where a source of AT is required.
Platelet lysate 4, Human
High purity preparation, in the tetrameric form, tested for its anti-heparin activity. In presence of heparin, this product offers an optimized binding capacity for heparin dependent antibodies developed in HIT (heparin induced thrombocytopenia).